The tyrosine phosphatase Shp2 is a potential target for the treatment of obesity and has a crucial role in glucose and lipid metabolism, and the development of adipose tissues.19–21 However, the regulatory effect of Shp2 on these processes is unclear. The gene discussed is PTPN11; the disease is obesity disorder.